The evidence-based group-level symptom-reduction model as the organizing principle for mental health care: time for change?

World Psychiatry

Volumn 18, Issue 1, 2019, Pages 88-96

  van Os, Jim ^a,b,c   Guloksuz, Sinan ^b,d   Vijn, Thomas Willem ^e   Hafkenscheid, Anton ^f   Delespaul, Philippe ^b,g  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f Arkin Sinai Centrum   (Netherlands)

^g Department PsyQ   (Netherlands)

Author keywords

e communities; evidence based practice; Mental health care; peer support; public health; recovery; relational components of care; resilience; trans syndromal symptom reduction

Indexed keywords

ARTICLE; DOCTOR PATIENT RELATION; EVIDENCE BASED PRACTICE; HUMAN; MENTAL HEALTH CARE; MENTAL HEALTH SERVICE; PEER GROUP; PRIORITY JOURNAL; PSYCHOLOGICAL RESILIENCE; PSYCHOTHERAPY; PUBLIC HEALTH; SOCIAL CARE; SUBSTANCE USE;

EID: 85055292134     PISSN: 17238617     EISSN: 20515545     Source Type: Journal    
DOI: 10.1002/wps.20609     Document Type: Article

References (104)

1. Greenhalgh T, Howick J, Maskrey N et al. Evidence based medicine: a movement in crisis? BMJ 2014;348:g3725.
2. Barbui C, Purgato M, Churchill R et al. Evidence-based interventions for global mental health: role and mission of a new Cochrane initiative. Cochrane Database Syst Rev 2017;4:ED000120.
3. Fisher AJ, Medaglia JD, Jeronimus BF. Lack of group-to-individual generalizability is a threat to human subjects research. Proc Natl Acad Sci USA 2018;115:E6106-15.
4. Miyar J, Adams CE. Content and quality of 10,000 controlled trials in schizophrenia over 60 years. Schizophr Bull 2013;39:226-9.
5. GBD 2013 DALYs and HALE Collaborators, Murray CJ, Barber RM et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet 2015;386:2145-91.
6. Vigo D, Thornicroft G, Atun R. Estimating the true global burden of mental illness. Lancet Psychiatry 2016;3:171-8.
7. Organisation for Economic Co-operation and Development. Antidepressant drugs consumption, 2000 and 2015 (or nearest year), in pharmaceutical sector. Paris: Organisation for Economic Co-operation and Development Publishing, 2017.
8. Steinhausen HC. Recent international trends in psychotropic medication prescriptions for children and adolescents. Eur Child Adolesc Psychiatry 2015;24:635-40.
9. Clark DM. Realizing the mass public benefit of evidence-based psychological therapies: the IAPT program. Annu Rev Clin Psychol 2018;14:159-83.
10. Wise J. Mental health: patients and service in crisis. BMJ 2017;356:j1141.
11. van Os J, Neeleman J. Caring for mentally ill people. BMJ 1994;309:1218-21.
12. Aarons GA, Glisson C, Green PD et al. The organizational social context of mental health services and clinician attitudes toward evidence-based practice: a United States national study. Implement Sci 2012;7:56.
13. Hasnain-Wynia R. Is evidence-based medicine patient-centered and is patient-centered care evidence-based? Health Serv Res 2006;41:1-8.
14. Slade M, Longden E. Empirical evidence about recovery and mental health. BMC Psychiatry 2015;15:285.
15. Wahlbeck K. Public mental health: the time is ripe for translation of evidence into practice. World Psychiatry 2015;14:36-42.
16. Sackett DL, Richardson WS, Rosenberg W et al. Evidence-based medicine. New York: Churchill Livingstone, 1997.
17. van Os J. A salience dysregulation syndrome. Br J Psychiatry 2009;194:101-3.
18. Maj M. Why the clinical utility of diagnostic categories in psychiatry is intrinsically limited and how we can use new approaches to complement them. World Psychiatry 2018;17:121-2.
19. Guloksuz S, van Os J. The slow death of the concept of schizophrenia and the painful birth of the psychosis spectrum. Psychol Med 2018;48:229-44.
20. Bell RC, Dudgeon P, McGorry PD et al. The dimensionality of schizophrenia concepts in first-episode psychosis. Acta Psychiatr Scand 1998;97:334-42.
21. Ahn WK, Proctor CC, Flanagan EH. Mental health clinicians' beliefs about the biological, psychological, and environmental bases of mental disorders. Cognit Sci 2009;33:47-82.
22. Barch DM, Bustillo J, Gaebel W et al. Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: relevance to DSM-5. Schizophr Res 2013;150:15-20.
23. Cuthbert BN, Insel TR. Toward new approaches to psychotic disorders: the NIMH Research Domain Criteria project. Schizophr Bull 2010;36:1061-2.
24. Kirsch I, Moncrieff J. Clinical trials and the response rate illusion. Contemp Cin Trials 2007;28:348-51.
25. Cuijpers P, Cristea IA, Karyotaki E et al. How effective are cognitive behavior therapies for major depression and anxiety disorders? A meta-analytic update of the evidence. World Psychiatry 2016;15:245-58.
26. Cuijpers P, van Straten A, Bohlmeijer E et al. The effects of psychotherapy for adult depression are overestimated: a meta-analysis of study quality and effect size. Psychol Med 2010;40:211-23.
27. Wampold BE, Fluckiger C, Del Re AC et al. In pursuit of truth: a critical examination of meta-analyses of cognitive behavior therapy. Psychother Res 2017;27:14-32.
28. Owen J, Drinane JM, Idigo KC et al. Psychotherapist effects in meta-analyses: how accurate are treatment effects? Psychotherapy 2015;52:321-8.
29. Leichsenring F, Abbass A, Hilsenroth MJ et al. Biases in research: risk factors for non-replicability in psychotherapy and pharmacotherapy research. Psychol Med 2017;47:1000-11.
30. Cipriani A, Furukawa TA, Salanti G et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 2018;391:1357-66.
31. Wampold BE. How important are the common factors in psychotherapy? An update. World Psychiatry 2015;14:270-7.
32. Rutherford BR, Wall MM, Glass A et al. The role of patient expectancy in placebo and nocebo effects in antidepressant trials. J Clin Psychiatry 2014;75:1040-6.
33. Cuijpers P, Donker T, van Straten A et al. Is guided self-help as effective as face-to-face psychotherapy for depression and anxiety disorders? A systematic review and meta-analysis of comparative outcome studies. Psychol Med 2010;40:1943-57.
34. Cuijpers P, Karyotaki E, Reijnders M et al. Was Eysenck right after all? A reassessment of the effects of psychotherapy for adult depression. Epidemiol Psychiatr Sci (in press).
35. Cristea IA, Gentili C, Cotet CD et al. Efficacy of psychotherapies for borderline personality disorder: a systematic review and meta-analysis. JAMA Psychiatry 2017;74:319-28.
36. Steenkamp MM, Litz BT, Hoge CW et al. Psychotherapy for military-related PTSD: a review of randomized clinical trials. JAMA 2015;314:489-500.
37. von Wolff A, Holzel LP, Westphal A et al. Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis. J Affect Disord 2013;144:7-15.
38. Samara MT, Dold M, Gianatsi M et al. Efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia: a network meta-analysis. JAMA Psychiatry 2016;73:199-210.
39. Cuijpers P, Sijbrandij M, Koole SL et al. The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons. World Psychiatry 2013;12:137-48.
40. Zipfel S, Wild B, Gross G et al. Focal psychodynamic therapy, cognitive behaviour therapy, and optimised treatment as usual in outpatients with anorexia nervosa (ANTOP study): randomised controlled trial. Lancet 2014;383:127-37.
41. Huhn M, Tardy M, Spineli LM et al. Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic overview of meta-analyses. JAMA Psychiatry 2014;71:706-15.
42. Ahn H, Wampold BE. Where oh where are the specific ingredients? A meta-analysis of component studies in counseling and psychotherapy. J Couns Psychol 2001;48:251-7.
43. Bell EC, Marcus DK, Goodlad JK. Are the parts as good as the whole? A meta-analysis of component treatment studies. J Consult Clin Psychol 2013;81:722-36.
44. Baldwin SA, Imel ZE. Therapist effects: findings and methods. In: Lambert MJ (ed). Bergin and Garfield's handbook of psychotherapy and behavior change, 6th ed. New York: Wiley, 2013:258-97.
45. McKay KM, Imel ZE, Wampold BE. Psychiatrist effects in the psychopharmacological treatment of depression. J Affect Disord 2006;92:287-90.
46. Khan A, Mar KF, Faucett J et al. Has the rising placebo response impacted antidepressant clinical trial outcome? Data from the US Food and Drug Administration 1987-2013. World Psychiatry 2017;16:181-92.
47. Rutherford BR, Pott E, Tandler JM et al. Placebo response in antipsychotic clinical trials: a meta-analysis. JAMA Psychiatry 2014;71:1409-21.
48. Leucht S, Chaimani A, Leucht C et al. 60 years of placebo-controlled antipsychotic drug trials in acute schizophrenia: meta-regression of predictors of placebo response. Schizophr Res (in press).
49. Tuttle AH, Tohyama S, Ramsay T et al. Increasing placebo responses over time in U.S. clinical trials of neuropathic pain. Pain 2015;156:2616-26.
50. Furukawa TA, Cipriani A, Leucht S et al. Is placebo response in antidepressant trials rising or not? A reanalysis of datasets to conclude this long-lasting controversy. Evid Based Ment Health 2018;21:1-3.
51. Tyrer P. Are small case-loads beautiful in severe mental illness? Br J Psychiatry 2000;177:386-7.
52. Johnsen TJ, Friborg O. The effects of cognitive behavioral therapy as an anti-depressive treatment is falling: a meta-analysis. Psychol Bull 2015;141:747-68.
53. Kaptchuk TJ, Kelley JM, Conboy LA et al. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ 2008;336:999-1003.
54. Kam-Hansen S, Jakubowski M, Kelley JM et al. Altered placebo and drug labeling changes the outcome of episodic migraine attacks. Sci Transl Med 2014;6:218ra5.
55. Fluckiger C, Del Re AC, Wampold BE et al. The alliance in adult psychotherapy: a meta-analytic synthesis. Psychotherapy (in press).
56. Cuijpers P, Huibers M, Ebert DD et al. How much psychotherapy is needed to treat depression? A metaregression analysis. J Affect Disord 2013;149:1-13.
57. Baskin TW, Tierney SC, Minami T et al. Establishing specificity in psychotherapy: a meta-analysis of structural equivalence of placebo controls. J Consult Clin Psychol 2003;71:973-9.
58. Iovieno N, Papakostas GI. Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis. J Clin Psychiatry 2012;73:1300-6.
59. Razza LB, Moffa AH, Moreno ML et al. A systematic review and meta-analysis on placebo response to repetitive transcranial magnetic stimulation for depression trials. Prog Neuropsychopharmacol Biol Psychiatry 2018;81:105-13.
60. Cuijpers P, Sijbrandij M, Koole SL et al. Adding psychotherapy to antidepressant medication in depression and anxiety disorders: a meta-analysis. World Psychiatry 2014;13:56-67.
61. Kramer I, Simons CJ, Hartmann JA et al. A therapeutic application of the experience sampling method in the treatment of depression: a randomized controlled trial. World Psychiatry 2014;13:68-77.
62. The Schizophrenia Commission. The abandoned illness. London: Rethink, 2012.
63. Van Sambeek N, Tonkens E, Bröer C. Sluipend kwaliteitsverlies in de geestelijke gezondheidszorg. Professionals over de gevolgen van marktwerking. Beleid en Maatschappij 2011;38:47-64.
64. Glasziou P, Moynihan R, Richards T et al. Too much medicine; too little care. BMJ 2013;347:f4247.
65. Huber M, Knottnerus JA, Green L et al. How should we define health? BMJ 2011;343:d4163.
66. Richards T, Snow R, Schroter S. Co-creating health: more than a dream. BMJ 2016;354:i4550.
67. Berwick DM. Era 3 for medicine and health care. JAMA 2016;315:329-30.
68. Emanuel EJ, Gudbranson E. Does medicine overemphasize IQ? JAMA 2018;319:651-2.
69. VanderWeele TJ, Balboni TA, Koh HK. Health and spirituality. JAMA 2017;318:519-20.
70. Deegan PE. Recovery and empowerment for people with psychiatric disabilities. Soc Work Health Care 1997;25:11-24.
71. Leamy M, Bird V, Le Boutillier C et al. Conceptual framework for personal recovery in mental health: systematic review and narrative synthesis. Br J Psychiatry 2011;199:445-52.
72. Stuart SR, Tansey L, Quayle E. What we talk about when we talk about recovery: a systematic review and best-fit framework synthesis of qualitative literature. J Ment Health 2017;26:291-304.
73. Anthony WA. Recovery from mental illness. The guiding vision of the mental health service system in the 1990s. Psychosoc Rehabil J 1993;16:11-23.
74. Boevink W. TREE: Towards recovery, empowerment and experiential expertise of users of psychiatric services. In: Rian P, Ramon S, Greacen T (eds). Empowerment, lifelong learning and recovery in mental health: towards a new paradigm. New York: Palgrave MacMillan, 2012:36-49.
75. Macpherson R, Pesola F, Leamy M et al. The relationship between clinical and recovery dimensions of outcome in mental health. Schizophr Res 2016;175:142-7.
76. Leamy M, Clarke E, Le Boutillier C et al. Implementing a complex intervention to support personal recovery: a qualitative study nested within a cluster randomised controlled trial. PLoS One 2014;9:e97091.
77. Stuber J, Rocha A, Christian A et al. Predictors of recovery-oriented competencies among mental health professionals in one community mental health system. Community Ment Health J 2014;50:909-14.
78. Rhenter P, Tinland A, Grard J et al. Problems maintaining collaborative approaches with excluded populations in a randomised control trial: lessons learned implementing Housing First in France. Health Res Policy Syst 2018;16:34.
79. Burhouse A, Rowland M, Marie Niman H et al. Coaching for recovery: a quality improvement project in mental healthcare. BMJ Qual Improv Rep 2015;4(1).
80. Buus N, Bikic A, Jacobsen EK et al. Adapting and implementing open dialogue in the Scandinavian countries: a scoping review. Issues Ment Health Nurs 2017;38:391-401.
81. Editorial. Open Dialogue method of mental health care launched in the UK. Ment Health Today 2015:6.
82. Tanenbaum SJ. Mental health consumer-operated services organizations in the US: citizenship as a core function and strategy for growth. Health Care Anal 2011;19:192-205.
83. Slade M. Implementing shared decision making in routine mental health care. World Psychiatry 2017;16:146-53.
84. Druss BG, Goldman HH. Integrating health and mental health services: a past and future history. Am J Psychiatry (in press).
85. Kuluski K, Ho JW, Hans PK et al. Community care for people with complex care needs: bridging the gap between health and social care. Int J Integr Care 2017;17:2.
86. Rodgers M, Dalton J, Harden M et al. Integrated care to address the physical health needs of people with severe mental illness: a mapping review of the recent evidence on barriers, facilitators and evaluations. Int J Integr Care 2018;18:9.
87. Baxter S, Johnson M, Chambers D et al. The effects of integrated care: a systematic review of UK and international evidence. BMC Health Serv Res 2018;18:350.
88. Allen D, Rixson L. How has the impact of ‘care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect? Int J Evid Based Healthc 2008;6:78-110.
89. Liu NH, Daumit GL, Dua T et al. Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agenda. World Psychiatry 2017;16:30-40.
90. Roy MJ, Donaldson C, Baker R et al. The potential of social enterprise to enhance health and well-being: a model and systematic review. Soc Sci Med 2014;123:182-93.
91. van Os J, Delespaul PH. A valid quality system for mental health care: from accountability and control in institutionalised settings to co-creation in small areas and a focus on community vital signs. Tijdschr Psychiatr 2018;60:96-104.
92. Fleury MJ, Mercier C. Integrated local networks as a model for organizing mental health services. Adm Policy Ment Health 2002;30:55-73.
93. Funk M, Ivbijaro G. Integrating mental health into primary care: a global perspective. Geneva: World Health Organization/WONCA, 2008.
94. London Strategic Clinical Network for Mental Health. A commissioner's guide to primary care mental health. London: London Strategic Clinical Network for Mental Health, 2014.
95. Adlington K. Pop a million happy pills? Antidepressants, nuance, and the media. BMJ 2018;360:k1069.
96. Dunlop AJ, Newman LK. ADHD and psychostimulants – overdiagnosis and overprescription. Med J Aust 2016;204:139.
97. Campion J, Knapp M. The economic case for improved coverage of public mental health interventions. Lancet Psychiatry 2018;5:103-5.
98. van Os J. ‘Multi-expert’ eCommunities as the basis of a novel system of public mental health. Tijdschrift voor Gezondheidswetenschappen 2018;96:62-7.
99. Griffiths KM. Mental health Internet support groups: just a lot of talk or a valuable intervention? World Psychiatry 2017;16:247-8.
100. Delespaul PH, de consensusgroep EPA. Consensus regarding the definition of persons with severe mental illness and the number of such persons in The Netherlands. Tijdschr Psychiatr 2013;55:427-38.
101. Davidson L, White W. The concept of recovery as an organizing principle for integrating mental health and addiction services. J Behav Health Serv Res 2007;34:109-20.
102. Vijn TW, Wollersheim H, Faber MJ et al. Building a patient-centered and interprofessional training program with patients, students and care professionals: study protocol of a participatory design and evaluation study. BMC Health Serv Res 2018;18:387.
103. McGorry PD, Tanti C, Stokes R et al. headspace: Australia's National Youth Mental Health Foundation – where young minds come first. Med J Aust 2007;187:S68-70.
104. Delespaul P, Milo M, Schalken F et al. GOEDE GGZ! Nieuwe concepten, aangepaste taal, verbeterde organisatie. Amsterdam: Diagnosis Uitgevers, 2016.